(Q35371261)

8 August 2017

1 reference

title

The prevention of atherosclerosis with antioxidants (English)

1 reference

8 August 2017

W. S. Harris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1395197

22 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1395197

22 September 2022

publication date

1 September 1992

1 reference

8 August 2017

1 reference

8 August 2017

volume

15

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

636-640

1 reference

The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholester

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

Alpha-tocopherol consumption during low-density-lipoprotein oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

The pharmacological treatment of dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Regulation of plasma cholesterol by lipoprotein receptors

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

The pathogenesis of atherosclerosis--an update

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Lipid peroxides and atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Alteration of plasma low density lipoprotein from smokers

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Low density lipoprotein undergoes oxidative modification in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Probucol inhibits oxidative modification of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Effect of probucol on the physical properties of low-density lipoproteins oxidized by copper

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

The antioxidant butylated hydroxytoluene protects against atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Oxidation of vitamin E in red cell membranes by fatty acids, hydroperoxides and selected oxidants

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Vitamin C and cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Vitamin E content and low density lipoprotein oxidizability induced by free radicals.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960150904

7 January 2021

Identifiers

DOI

10.1002/CLC.4960150904

1 reference

8 August 2017

1 reference